Dermira, Inc. (DERM) Social Stream
Warning: This security is no longer trading.
Eli Lilly completes acquisition of Dermira
Journey Medical Corp (DERM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Journey Medical Corp.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-07 | 1 | $14 | $14 | $14 | $4.85 | 188.66% |
| 2022-01-13 | 2 | $15 | $14 | $14.5 | $4.85 | 198.97% |
| 2022-03-25 | 3 | $17 | $9 | $13.333 | $4.85 | 174.91% |
| NA | 1 | $NA | $NA | $NA | $4.85 | NA% |
Over the past 108 days, DERM's average upside potential has been 157.15%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-07 | 1 | 14 | 14 | 14.0 | 7.27 | 92.57% |
| 2022-01-13 | 3 | 15 | 14 | 14.5 | 5.18 | 179.92% |
| 2022-01-13 | 2 | 15 | 14 | 14.5 | 5.18 | 179.92% |
| 2022-01-13 | 3 | 17 | 14 | 15.5 | 5.18 | 199.23% |
| 2022-01-13 | 2 | 17 | 14 | 15.5 | 5.18 | 199.23% |
DERM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Journey Medical Corp's number of analysts covering the stock is higher than 31.7% of them.
- In the context of all US stocks, Journey Medical Corp's upside potential (average analyst target price relative to current price) is higher than 439.16% of them.
- DERM has a greater average analyst price target than 76.62% of all US stocks.
- Journey Medical Corp's variance in analysts' estimates is lower than 0.52% of Healthcare stocks.
In the Pharmaceutical Products industry, DARE, CYCC, and CWBR are the three stocks most similar to Journey Medical Corp regarding the price target and analyst recommendation information presented here.
Is DERM a Buy, Hold or Sell? See the POWR Ratings now!